Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC‐Norfolk prospective population‐based cohort study

BACKGROUND: Higher medication anticholinergic burden is associated with increased risk of cardiovascular disease and cognitive decline. A mechanistic pathway has not been established. We aimed to determine whether inflammation may mediate these associations. METHODS: Participants were drawn from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanghavi, Ria, Pana, Tiberiu A., Mamayusupova, Hulkar, Maidment, Ian, Fox, Chris, Boekholdt, S. Matthijs, Mamas, Mamas A., Wareham, Nicholas J., Khaw, Kay‐Tee, Myint, Phyo K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373850/
https://www.ncbi.nlm.nih.gov/pubmed/35118716
http://dx.doi.org/10.1111/bcp.15261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373850/
https://www.ncbi.nlm.nih.gov/pubmed/35118716
http://dx.doi.org/10.1111/bcp.15261

Ejemplares similares